haloperidol and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

haloperidol has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carmody, LC; Dandapani, S; Donckele, E; Feng, Y; Fernandez, C; Germain, AR; Gupta, PB; Lander, ES; Morgan, B; Munoz, B; Nag, PP; Palmer, M; Perez, JR; Schreiber, SL; Verplank, L1
Buckalew, VM; Handa, RK; Strandhoy, JW2

Other Studies

3 other study(ies) available for haloperidol and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

ArticleYear
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
    Bioorganic & medicinal chemistry letters, 2013, Mar-15, Volume: 23, Issue:6

    Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Small Molecule Libraries; Structure-Activity Relationship

2013
Selective inhibition of vasoconstrictor responses by platelet-activating factor in rat kidney.
    The American journal of physiology, 1991, Volume: 261, Issue:1 Pt 2

    Topics: Animals; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Calcium Channel Blockers; Dopamine Antagonists; Dose-Response Relationship, Drug; Furans; Gallic Acid; Haloperidol; Hematocrit; Male; Nimodipine; Platelet Activating Factor; Potassium Chloride; Rats; Rats, Inbred Strains; Renal Circulation; Vasoconstriction

1991
Platelet-activating factor is a renal vasodilator in the anesthetized rat.
    The American journal of physiology, 1990, Volume: 258, Issue:6 Pt 2

    Topics: Anesthesia; Animals; Eicosanoids; Haloperidol; Indomethacin; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains; Receptors, Dopamine; Renal Circulation; Vasodilator Agents

1990